Cierra N. Sharp

Cierra N. Sharp

Aug 15, 2016

Group 6 Copy 21
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Saving Tropical Migratory Bird Habitat

    Migratory birds, songbirds in particular, over-winter in the tropics. Much of the land is being deforested to...

    Household Composting Toilets for Agriculture in Malawi

    Ninety percent of Malawi does not have access to improved sanitation. 90% of the people also work in agriculture...

    What Did 17th-Century Sailors Really Eat?

    Were sailors actually ship-shape--or were they truly a sickly bunch? Find out with us! We are replicating shipboard...

    Backer Badge Funded